Sentence examples for mg at week from inspiring English sources

Dosing for eculizumab was 900 mg on day 1 and at weeks 1, 2, and 3; 1200 mg at week 4; and 1200 mg given every second week thereafter as maintenance dosing.

The total daily dose of fluvoxamine ranged from 100 to 300 mg with a mean daily dose of 150 mg at week 14.

The adalimumab-treated patients received a subcutaneous injection of 160 mg at week 0 and an injection of 80 mg at week 2.

aTreatment with 3 mg started at Week 16, and the dose was increased to 5 mg at Week 18 and to 10 mg at Week 24.

Methotrexate was initially dosed at 7.5 mg/week and subsequently increased to 15 mg at week 4 and to 20 mg at week 8, at which dose it was maintained until study completion.

RLAI 25 mg every 2 weeks was initiated at open-label baseline, with optional dosage increases to 37.5 mg at week 4 and to 50 mg at week 10 (per the investigators' clinical judgment).

In this multicenter, randomized, double-blind, placebo-controlled, Phase III study, eligible patients with CM were randomized 1 1 1 to receive subcutaneous injections of fremanezumab quarterly dosing (675 mg at baseline and placebo at Weeks 4 and 8), fremanezumab monthly dosing (675 mg at baseline and 225 mg at Weeks 4 and 8), or placebo at each time point over a 12-week treatment period.

In this multicenter, randomized, double-blind, placebo-controlled study, patients with CM were randomized 1 1 1 to receive subcutaneous injections of fremanezumab quarterly dosing (675 mg at baseline and placebo at Weeks 4 and 8), fremanezumab monthly dosing (675 mg at baseline and 225 mg at Weeks 4 and 8), or placebo at each time point over a 12-week treatment period.

All patients received initial open-label adalimumab induction therapy (80 mg/40 mg at weeks 0/2).

Patients received subcutaneous CZP 400 mg at weeks 0, 2 and 4 and every 4 weeks up to week 52.

After the study began, at the request of the European regulatory authorities, the protocol was amended to add a second adalimumab induction group of 80/40 mg at weeks 0/2, followed by 40 mg at weeks 4/6.